Lifecore Biomedical Stock Technical Analysis
| LFCR Stock | 8.69 0.13 1.52% |
As of the 29th of January, Lifecore Biomedical secures the Mean Deviation of 2.1, downside deviation of 2.2, and Risk Adjusted Performance of 0.1085. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lifecore Biomedical, as well as the relationship between them. Please verify Lifecore Biomedical information ratio, as well as the relationship between the potential upside and kurtosis to decide if Lifecore Biomedical is priced some-what accurately, providing market reflects its recent price of 8.69 per share. Given that Lifecore Biomedical has jensen alpha of 0.2865, we recommend you to check Lifecore Biomedical's last-minute market performance to make sure the company can sustain itself at a future point.
Lifecore Biomedical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lifecore, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LifecoreLifecore Biomedical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Lifecore Biomedical Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 9.25 | Strong Buy | 3 | Odds |
Most Lifecore analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Lifecore stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Lifecore Biomedical, talking to its executives and customers, or listening to Lifecore conference calls.
Can Biotechnology industry sustain growth momentum? Does Lifecore have expansion opportunities? Factors like these will boost the valuation of Lifecore Biomedical. Expected growth trajectory for Lifecore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Lifecore Biomedical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.27) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Understanding Lifecore Biomedical requires distinguishing between market price and book value, where the latter reflects Lifecore's accounting equity. The concept of intrinsic value—what Lifecore Biomedical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Lifecore Biomedical's price substantially above or below its fundamental value.
Understanding that Lifecore Biomedical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lifecore Biomedical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lifecore Biomedical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Lifecore Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lifecore Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lifecore Biomedical.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Lifecore Biomedical on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Lifecore Biomedical or generate 0.0% return on investment in Lifecore Biomedical over 90 days. Lifecore Biomedical is related to or competes with BioAge Labs, Alpha Teknova, Canopy Growth, Sight Sciences, ProQR Therapeutics, Aurora Cannabis, and Immutep. Lifecore Biomedical is entity of United States More
Lifecore Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lifecore Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lifecore Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.2 | |||
| Information Ratio | 0.1108 | |||
| Maximum Drawdown | 15.24 | |||
| Value At Risk | (4.01) | |||
| Potential Upside | 6.17 |
Lifecore Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifecore Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lifecore Biomedical's standard deviation. In reality, there are many statistical measures that can use Lifecore Biomedical historical prices to predict the future Lifecore Biomedical's volatility.| Risk Adjusted Performance | 0.1085 | |||
| Jensen Alpha | 0.2865 | |||
| Total Risk Alpha | 0.128 | |||
| Sortino Ratio | 0.141 | |||
| Treynor Ratio | 0.2747 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lifecore Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lifecore Biomedical January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1085 | |||
| Market Risk Adjusted Performance | 0.2847 | |||
| Mean Deviation | 2.1 | |||
| Semi Deviation | 2.04 | |||
| Downside Deviation | 2.2 | |||
| Coefficient Of Variation | 727.02 | |||
| Standard Deviation | 2.8 | |||
| Variance | 7.84 | |||
| Information Ratio | 0.1108 | |||
| Jensen Alpha | 0.2865 | |||
| Total Risk Alpha | 0.128 | |||
| Sortino Ratio | 0.141 | |||
| Treynor Ratio | 0.2747 | |||
| Maximum Drawdown | 15.24 | |||
| Value At Risk | (4.01) | |||
| Potential Upside | 6.17 | |||
| Downside Variance | 4.84 | |||
| Semi Variance | 4.16 | |||
| Expected Short fall | (2.55) | |||
| Skewness | 0.7888 | |||
| Kurtosis | 1.44 |
Lifecore Biomedical Backtested Returns
Lifecore Biomedical appears to be somewhat reliable, given 3 months investment horizon. Lifecore Biomedical has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Lifecore Biomedical, which you can use to evaluate the volatility of the firm. Please exercise Lifecore Biomedical's Risk Adjusted Performance of 0.1085, downside deviation of 2.2, and Mean Deviation of 2.1 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lifecore Biomedical holds a performance score of 9. The company secures a Beta (Market Risk) of 1.37, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lifecore Biomedical will likely underperform. Please check Lifecore Biomedical's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Lifecore Biomedical's current price movements will revert.
Auto-correlation | -0.01 |
Very weak reverse predictability
Lifecore Biomedical has very weak reverse predictability. Overlapping area represents the amount of predictability between Lifecore Biomedical time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lifecore Biomedical price movement. The serial correlation of -0.01 indicates that just 1.0% of current Lifecore Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Lifecore Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Lifecore Biomedical Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Lifecore Biomedical across different markets.
About Lifecore Biomedical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lifecore Biomedical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lifecore Biomedical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lifecore Biomedical price pattern first instead of the macroeconomic environment surrounding Lifecore Biomedical. By analyzing Lifecore Biomedical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lifecore Biomedical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lifecore Biomedical specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Days Sales Outstanding | 123.68 | 46.7 | 44.34 | PTB Ratio | 175.14 | 0.7 | 0.67 |
Lifecore Biomedical January 29, 2026 Technical Indicators
Most technical analysis of Lifecore help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lifecore from various momentum indicators to cycle indicators. When you analyze Lifecore charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1085 | |||
| Market Risk Adjusted Performance | 0.2847 | |||
| Mean Deviation | 2.1 | |||
| Semi Deviation | 2.04 | |||
| Downside Deviation | 2.2 | |||
| Coefficient Of Variation | 727.02 | |||
| Standard Deviation | 2.8 | |||
| Variance | 7.84 | |||
| Information Ratio | 0.1108 | |||
| Jensen Alpha | 0.2865 | |||
| Total Risk Alpha | 0.128 | |||
| Sortino Ratio | 0.141 | |||
| Treynor Ratio | 0.2747 | |||
| Maximum Drawdown | 15.24 | |||
| Value At Risk | (4.01) | |||
| Potential Upside | 6.17 | |||
| Downside Variance | 4.84 | |||
| Semi Variance | 4.16 | |||
| Expected Short fall | (2.55) | |||
| Skewness | 0.7888 | |||
| Kurtosis | 1.44 |
Lifecore Biomedical January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Lifecore stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.01 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 8.63 | ||
| Day Typical Price | 8.65 | ||
| Price Action Indicator | 0.13 | ||
| Market Facilitation Index | 0.13 |
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.